The number of people with susceptibility test result for rifampicin in Bhutan
Bhutan: The number of people with susceptibility test result for rifampicin was 96.77 in 2021. ▲ Rising
Latest (2021)
96.77
Change on year
down 3.2%
World rank
40th
of 146 countries
All-time high
100
in 2019
All-time low
88.13
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Bhutan, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Bhutan stood at 96.77.
The figure is down 3.2% on the previous year and up 3.5% over five years.
Bhutan ranks 40th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Bhutan, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 93.53 | — |
| 2018 | 88.13 | -5.8% |
| 2019 | 100 | +13.5% |
| 2020 | 100 | +0.0% |
| 2021 | 96.77 | -3.2% |
Bhutan compared with similar countries
- Bhutan's 96.77 is above the median for lower middle income countries, which is 78.77, 1.2× the median. (32 countries reporting)
- Bhutan's 96.77 is above the median for South Asia, which is 81.26, 1.2× the median. (5 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 93.89 | 88.13 | 100 | 3 |
| 2020s | 98.38 | 96.77 | 100 | 2 |
Countries ranked near Bhutan
More health data for Bhutan
- Un projection of annual infant deaths, annual growth rate -10 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0915 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,531 deaths per 1,000 people (2090)
- Number of infants who die before age 1 9 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.2986 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0299 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.3987 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Bhutan?
- The number of people with susceptibility test result for rifampicin in Bhutan was 96.77 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Bhutan?
- The highest recorded value was 100 in 2019.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Bhutan?
- The lowest recorded value was 88.13 in 2018.
- How does Bhutan rank for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 40th out of 146 countries with data for 2021.
- Where does this Bhutan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).